Femto Technologies Secures $17 Million Investment to Advance Feminine Wellness Technology

Femto Technologies Inc. has successfully secured $17 million through a private placement investment, positioning the company to advance its innovative feminine wellness technologies. The funding round involves the issuance of common shares and warrants to institutional investors at $4.17 per common unit, with the transaction scheduled to close on February 27, 2025. This financial backing represents a significant milestone for the FemTech pioneer as it seeks to expand its technological offerings in the growing feminine wellness market.

The investment structure includes the sale of common units comprising common shares, Series A warrants, and Series B PIPE common warrants. Series A warrants feature an initial exercise price of $5.21 per common share and will expire 60 months after issuance, while Series B warrants carry an initial exercise price of $12.51 per common share with a 30-month expiration period. Aegis Capital Corp. is serving as the exclusive placement agent for this private placement, which is being offered solely to accredited investors in a transaction not involving a public offering.

Femto Technologies plans to utilize the net proceeds from the offering for general corporate purposes and working capital, with specific focus on advancing development of its flagship product, Sensera. The feminine wellness device integrates proprietary Smart Release System technology that incorporates machine learning and artificial intelligence capabilities. The Sensera device recently received a CES Innovation Awards® 2025 Honorary designation in the AI category, recognizing its innovative approach to feminine wellness technology.

The company's technological platform represents a significant advancement in addressing gaps in feminine wellness through sophisticated technological solutions. The device is engineered to provide a comprehensive self-care experience that dynamically adapts to women's changing physiological needs. This funding achievement underscores Femto Technologies' strategic positioning within the emerging FemTech market and signals continued innovation potential in female wellness technologies. The private placement securities have not been registered under the Securities Act of 1933, reflecting the specialized nature of this investment transaction.